These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22732464)

  • 1. Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo.
    Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Nku D; Napravnik S; Cole SR; Van Rie A; Behets F
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):90-8. PubMed ID: 22732464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.
    Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Napravnik S; Cole SR; Van Rie A; Behets F
    PLoS Med; 2011 Jun; 8(6):e1001044. PubMed ID: 21695087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.
    Nugent J; Edmonds A; Lusiama J; Thompson D; Behets F;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1148-55. PubMed ID: 24945879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
    Panayidou K; Davies MA; Anderegg N; Egger M;
    J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is Associated With Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo.
    Feinstein L; Edmonds A; Okitolonda V; Cole SR; Van Rie A; Chi BH; Ndjibu P; Lusiama J; Chalachala JL; Behets F
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e93-9. PubMed ID: 25886922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo.
    Aketi L; Tshibassu PM; Kayembe PK; Kitetele F; Edidi S; Ekila MB; Wumba R; Lepira FB; Aloni MN
    Pathog Glob Health; 2015 Sep; 109(6):300-4. PubMed ID: 26182826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo.
    Chabikuli ON; Ditekemena JD; Sigwadhi LN; Mulenga A; Mboyo A; Bidashimwa D; Nachega JB
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231221955. PubMed ID: 38146172
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.
    Han WM; Apornpong T; Handoko R; Jantarabenjakul W; Gatechompol S; Ubolyam S; Kerr SJ; Avihingsanon A; Ruxrungtham K; Phanuphak P; Puthanakit T
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):88-96. PubMed ID: 32188991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children.
    Guillén S; Prieto L; Jiménez de Ory S; González-Tomé MI; Rojo P; Navarro ML; Mellado MJ; Escosa L; Sainz T; Francisco L; Muñoz-Fernández MÁ; Ramos JT;
    PLoS One; 2019; 14(8):e0220552. PubMed ID: 31381604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.
    Edmonds A; Lusiama J; Napravnik S; Kitetele F; Van Rie A; Behets F
    Int J Epidemiol; 2009 Dec; 38(6):1612-21. PubMed ID: 19448046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
    Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
    Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.
    Gkentzi D; Tebruegge M; Tudor-Williams G; Walters S; Lyall H; Sharland M; Doerholt K
    Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.
    Ditekemena J; Luhata C; Bonane W; Kiumbu M; Tshefu A; Colebunders R; Koole O
    PLoS One; 2014; 9(12):e113877. PubMed ID: 25541707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
    Pantazis N; Papastamopoulos V; Paparizos V; Metallidis S; Adamis G; Antoniadou A; Psichogiou M; Chini M; Sambatakou H; Sipsas NV; Gogos C; Chrysos G; Panagopoulos P; Katsarou O; Gikas A; Touloumi G;
    AIDS; 2019 Aug; 33(10):1645-1655. PubMed ID: 31305332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.